Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2083562728;62729;62730 chr2:178589222;178589221;178589220chr2:179453949;179453948;179453947
N2AB1919457805;57806;57807 chr2:178589222;178589221;178589220chr2:179453949;179453948;179453947
N2A1826755024;55025;55026 chr2:178589222;178589221;178589220chr2:179453949;179453948;179453947
N2B1177035533;35534;35535 chr2:178589222;178589221;178589220chr2:179453949;179453948;179453947
Novex-11189535908;35909;35910 chr2:178589222;178589221;178589220chr2:179453949;179453948;179453947
Novex-21196236109;36110;36111 chr2:178589222;178589221;178589220chr2:179453949;179453948;179453947
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAG
  • RefSeq wild type template codon: TTC
  • Domain: Ig-122
  • Domain position: 67
  • Structural Position: 145
  • Q(SASA): 0.7189
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/E rs765319119 0.487 0.002 N 0.181 0.152 0.350746614512 gnomAD-2.1.1 8.04E-06 None None None None N None 0 5.8E-05 None 0 0 None 0 None 0 0 0
K/E rs765319119 0.487 0.002 N 0.181 0.152 0.350746614512 gnomAD-4.0.0 1.59182E-06 None None None None N None 0 2.28739E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.4102 ambiguous 0.4583 ambiguous -0.036 Destabilizing 0.067 N 0.408 neutral None None None None N
K/C 0.6223 likely_pathogenic 0.6857 pathogenic -0.137 Destabilizing 0.935 D 0.555 neutral None None None None N
K/D 0.7712 likely_pathogenic 0.8195 pathogenic 0.198 Stabilizing 0.081 N 0.399 neutral None None None None N
K/E 0.3122 likely_benign 0.3601 ambiguous 0.21 Stabilizing 0.002 N 0.181 neutral N 0.480878498 None None N
K/F 0.8193 likely_pathogenic 0.8513 pathogenic -0.207 Destabilizing 0.555 D 0.491 neutral None None None None N
K/G 0.5267 ambiguous 0.548 ambiguous -0.259 Destabilizing 0.149 N 0.43 neutral None None None None N
K/H 0.3753 ambiguous 0.4262 ambiguous -0.589 Destabilizing 0.555 D 0.457 neutral None None None None N
K/I 0.3971 ambiguous 0.4612 ambiguous 0.476 Stabilizing 0.555 D 0.487 neutral None None None None N
K/L 0.4061 ambiguous 0.4566 ambiguous 0.476 Stabilizing 0.149 N 0.435 neutral None None None None N
K/M 0.2903 likely_benign 0.3457 ambiguous 0.372 Stabilizing 0.915 D 0.447 neutral N 0.488507621 None None N
K/N 0.6064 likely_pathogenic 0.6757 pathogenic 0.29 Stabilizing 0.117 N 0.419 neutral N 0.510086684 None None N
K/P 0.9545 likely_pathogenic 0.9486 pathogenic 0.334 Stabilizing 0.555 D 0.436 neutral None None None None N
K/Q 0.1518 likely_benign 0.1726 benign 0.085 Stabilizing 0.117 N 0.451 neutral N 0.461274017 None None N
K/R 0.0828 likely_benign 0.0826 benign -0.01 Destabilizing None N 0.143 neutral N 0.483766874 None None N
K/S 0.5197 ambiguous 0.5837 pathogenic -0.269 Destabilizing 0.149 N 0.386 neutral None None None None N
K/T 0.2169 likely_benign 0.268 benign -0.1 Destabilizing 0.117 N 0.415 neutral N 0.439706666 None None N
K/V 0.3113 likely_benign 0.3608 ambiguous 0.334 Stabilizing 0.38 N 0.423 neutral None None None None N
K/W 0.8296 likely_pathogenic 0.8459 pathogenic -0.177 Destabilizing 0.935 D 0.621 neutral None None None None N
K/Y 0.7336 likely_pathogenic 0.7765 pathogenic 0.179 Stabilizing 0.555 D 0.487 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.